The course of COVID-19 in patients with hematological malignancies and risk factors affecting mortality: A cross-sectional study

Objective: This study aimed to determine the clinical outcomes and risk factors affecting mortality in patients with COVID-19 following hematological malignancy (HM). Methods: Patients diagnosed with HM and hospitalized for COVID-19 were included in this retrospective study. The age, demographic and...

Full description

Bibliographic Details
Main Authors: Esma Eryilmaz-Eren, Zeynep Ture, Ayşin Kilinç-Toker, Serdal Korkmaz, İlhami Çelik
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137922014602